Dare Bioscience Inc (NAS:DARE)
$ 3.18 -0.01 (-0.31%) Market Cap: 27.75 Mil Enterprise Value: 21.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Q3 2022 Dare Bioscience Inc Earnings Call Transcript

Nov 10, 2022 / 09:30PM GMT
Release Date Price: $11.03 (-2.21%)
Operator

Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the quarter ended September 30, 2022, and to provide a general business update. This call is being recorded. My name is Paula, and I will be your operator today. With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Daré's Chief Strategy Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer. Ms. Johnson, please proceed.

Sabrina Martucci Johnson;Bioscience
DarÃ;Inc. - President, CEO, Secretary & Director

© -

Thank you. Good afternoon, and welcome to our third quarter of 2022 financial results and business update call for Daré Bioscience. Our plan today is to review our third quarter results, discuss developments since our last call in August and use the time to review our business strategy, including why we believe investment in women's health is efficient and disproportionately impactful and to highlight some important objectives and milestones anticipated through the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot